Endogenous stimuli-responsive separating microneedles to inhibit hypertrophic scar through remodeling the pathological microenvironment

• Published in: Nature communications Vol. 15; no. 1; p. 2038
• Main Authors: Yang, Zhuo-Ran, Suo, Huinan, Fan, Jing-Wen, Lv, Niannian, Du, Kehan, Ma, Teng, Qin, Huimin, Li, Yan, Yang, Liu, Zhou, Nuoya, Jiang, Hao, Tao, Juan, Zhu, Jintao
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 06.03.2024; Nature Publishing Group UK; Nature Portfolio
• Subjects: 5-Fluorouracil; Animals; Bcl-2 protein; Bioavailability; Biological Availability; Cell Differentiation; Cicatrix, Hypertrophic - drug therapy; Down-regulation; Drug delivery; Drug delivery systems; Dystroglycan; Endogenous stimuli; Eutrophication; Female; Females; Fibrosis; Gene sequencing; Growth factors; Humans; Inflammation; Inflammatory response; Interleukin 1; Interleukin 1 receptors; Keratinocytes; Matrix metalloproteinase; Matrix Metalloproteinases; Mice; Microenvironments; Needles; Oxygen; Proteoglycans; Rabbits; Reactive Oxygen Species; Scavenging; Toll-like receptors
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-024-46328-2

Hypertrophic scar (HS) considerably affects the appearance and causes tissue dysfunction in patients. The low bioavailability of 5-fluorouracil poses a challenge for HS treatment. Here we show a separating microneedle (MN) consisting of photo-crosslinked GelMA and 5-FuA-Pep-MA prodrug in response to high reactive oxygen species (ROS) levels and overexpression of matrix metalloproteinases (MMPs) in the HS pathological microenvironment. In vivo experiments in female mice demonstrate that the retention of MN tips in the tissue provides a slowly sustained drug release manner. Importantly, drug-loaded MNs could remodel the pathological microenvironment of female rabbit ear HS tissues by ROS scavenging and MMPs consumption. Bulk and single cell RNA sequencing analyses confirm that drug-loaded MNs could reverse skin fibrosis through down-regulation of BCL-2-associated death promoter (BAD), insulin-like growth factor 1 receptor (IGF1R) pathways, simultaneously regulate inflammatory response and keratinocyte differentiation via up-regulation of toll-like receptors (TOLL), interleukin-1 receptor (IL1R) and keratinocyte pathways, and promote the interactions between fibroblasts and keratinocytes via ligand-receptor pair of proteoglycans 2 (HSPG2)-dystroglycan 1(DAG1). This study reveals the potential therapeutic mechanism of drug-loaded MNs in HS treatment and presents a broad prospect for clinical application.